# FDA recall D-0150-2025

> **Provepharm Inc.** · Class II · drug recall initiated 2024-11-22.

## Product

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

## Reason for recall

Discoloration

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0150-2025
- **Recalling firm:** Provepharm Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-11-22
- **Report date:** 2024-12-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Collegeville, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0150-2025

## Citation

> AI Analytics. FDA recall D-0150-2025. Retrieved 2026-07-18 from https://api.ai-analytics.org/recall/D-0150-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*